Primary squamous cell carcinoma arising from endometriosis of the ovary: A case report and literature review
review
OA: closed
CC0
⤵ 9 in-corpus citations
AI-generated summary
This report details a rare case of primary squamous cell carcinoma originating from ovarian endometriosis and reviews existing literature on this phenomenon.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Cases of squamous cell carcinoma (SCC) arising from ovarian endometriosis have been rarely reported. Most of the patients show a poor prognosis and present with a diminished survival time. We present a SCC case arising from endometriosis, and analyzed the clinical, therapeutic, and pathologic features through a comprehensive literature review. A 43-year premenopausal woman (gravida 2, para 1) presented to our hospital due to sudden pain in lower abdomen. Exploratory laparotomy indicated rupture of left ovarian cyst and intra-abdominal hemorrhage were observed. Frozen section pathologic examination indicated malignant ovarian (left-sided) epithelial tumor (poorly differentiated squamous carcinoma). She received hysterectomy, adnexectomy, and omentectomy. Initially, the patient received 3 cycles of chemotherapy using paclitaxel and cisplatin via peritoneal injection. Subsequently, the regimen was altered to 2 cycles of paclitaxel or cisplatin chemotherapy through intravenous injection due to poor tolerance. Upon diagnosis of vaginal metastasis, 2 cycles of chemotherapy was performed using cisplatin, doxorubicin, and cyclophosphamide. Pathologic analysis revealed massive poorly differentiated squamous carcinoma in the fibrous tissues. Besides, cancer embolus was noticed in the lymphatic vessels. Besides our case, 20 cases of infiltrating SCC of the ovary associated with or arising from endometriosis were found. The tumor was associated with 80% patient mortality in the first few months. Adjuvant chemotherapy with paclitaxel and carboplatin or cisplatin appeared to contribute to the survival duration. The best outcomes were obtained in patients received paclitaxel and carboplatin or cisplatin after radical surgery. In future, further studies are needed to validate the efficiency of such regimen.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- A case of ovarian adenosquamous carcinoma arising from endometrioid adenocarcinoma: a case report and systematic review via openalex
- A case of squamous cell carcinoma arising from endometriosis of the ovary. via openalex
- Clinicopathologic features of ovarian cancer in patients with ovarian endometrioma via openalex
- Endometriosis-related malignancies via openalex
- Endometriosis-related malignancies via openalex
- Genes’ Interactions: A Major Contributor to the Malignant Transformation of Endometriosis via openalex
- Malignancy arising in extragonadal endometriosis.A case report and summary of the world literature via openalex
- Malignant degeneration of rectal endometriosis via openalex
- Ovarian endometriosis associated with carcinoma and sarcoma: case report. via openalex
- Overexpression of TGF‑β enhances the migration and invasive ability of ectopic endometrial cells via ERK/MAPK signaling pathway via openalex
- Primary squamous cell carcinoma associated with ovarian endometriosis: a case report and literature review via openalex
- Pure Primary Squamous Cell Carcinoma of the Ovary: A Report of Two Cases and Review of the Literature via openalex
- Remarkable Response of Primary Squamous Cell Carcinoma of the Ovary to Paclitaxel and Cisplatin via openalex
- Squamous cell carcinoma arising in endometriosis. via openalex
- Squamous cell carcinoma arising in ovarian endometriosis via openalex
- W2004934649 via openalex
- W2049367965 via openalex
- W2069139787 via openalex
- W2102628822 via openalex
- W2157372421 via openalex
- W2202325181 via openalex
- W1989827701 via openalex
- W2504181072 via openalex
- W2028762731 via openalex
- W2592169532 via openalex
- W2606194107 via openalex
- W2623929273 via openalex
- W2731087687 via openalex
- W1965429276 via openalex
- W2023271527 via openalex
- W1217546671 via openalex
- W4244876072 via openalex
- W6601766159 via openalex
- W6602133524 via openalex
- W6664422473 via openalex
- W6687785150 via openalex
- W6718720111 via openalex
- W6738938789 via openalex
- W6740949651 via openalex
- W2037359716 via openalex
- W2043099617 via openalex
Cited by (9)
- Primary squamous cell carcinoma of the uterine wall associated with adenomyosis: A rare case report and literature review 2025
- Ovarian squamous cell carcinoma associated with endometriosis 2024
- Mixed squamous and clear cell ovarian adenocarcinoma arising from endometriosis in a 71 year old patient 2023
- Indian Medicinal Plants for the Management of Endometriosis: A Comprehensive Review on their phytopharmacology 2023
- Atypical endometriosis: a review of an incompletely understood putative precursor of endometriosis-associated ovarian carcinoma 2023
- Squamous cell carcinoma associated with endometriosis in the uterus and ovaries: A case report 2023
- Retroperitoneal Squamous Cell Carcinoma Involving the Pelvic Side Wall Arising from Endometriosis: A Case Report 2022
- Overexpression of TGF‑β enhances the migration and invasive ability of ectopic endometrial cells via ERK/MAPK signaling pathway 2019
- Genes’ Interactions: A Major Contributor to the Malignant Transformation of Endometriosis 2019
Source provenance
- europepmc
- last seen: 2026-07-30T06:25:42.655704+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:19:55.107525+00:00
License: CC0
· commercial use OK